This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Nerixia

Abiogen Pharma SpA

Drug Names(s): Attila (China, Hong Kong, Macau, Taiwan), Neridronate, Neridronic Acid

Description: Neridronate is an amino-bisphosphonate used in metabolic osteopathy.

Deal Structure: Abiogen and Lee's
In April 2014, Lees Pharmaceutical and Abiogen announced the signing of an agreement for License, Distribution and Supply for marketing of Attila (Neridronic Acid) throughout China, Hong Kong, Macau and Taiwan. Under the term of agreement, Lees granted an exclusive license and right for registering, importing, marketing, distributing and selling the Sodium Neridronate finished products (25mg/2ml, solution for injection and 100mg/8ml, concentrate for solution for infusion) in the territory, for the two disease indications as Osteogenesis Imperfecta and Complex Regional Pain Syndrome (Algodistrophy).

Partners: Lee's Pharmaceutical Holdings Limited


Nerixia News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug